Mandate

Vinge is advising on the establishment of Ballista Capital

July 07, 2025

Ballista Capital held its final closing on 9 June 2025. The investor base primarily comprises family offices and investors with strong ties to northern Sweden.

Ballista Capital believes in the potential to generate returns by investing in Swedish small and medium-sized companies that are often overlooked by larger capital flows, with a particular focus on businesses located outside the major metropolitan areas.

Vinge's team primarily consisted of Mattias Schömer, Marcus Andersson, Semir Omerbasic, Erik Kochbati and Emelie Zingmark

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026